Remove Events Remove Immunization Remove Labelling
article thumbnail

Oral penicillin challenge deemed safe and effective in low-risk allergy patients

Hospital Pharmacy Europe

Removing the label of being allergic to penicillin involves intra-dermal skin testing followed by an oral penicillin challenge. The primary outcome of interest was a physician-verified positive immune-mediated oral penicillin challenge within one hour after the intervention. None of these were deemed to be serious.

article thumbnail

EMA panel probes heart inflammation with Pfizer/BioNTech COVID vaccine

pharmaphorum

At the moment, there’s no indication that the cases are linked to the vaccine itself, but the EMA has asked the companies to provide “further detailed data, including an analysis of the events according to age and gender,” as it looks into the signal.

Vaccines 122
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

First patient dosed with HIV gene therapy

European Pharmaceutical Review

The removal of HIV DNA from the cellular genome is essential to effecting a cure; the virus takes up long-term residence in tissue reservoirs, where it hides, evading the immune system and escaping antiretroviral therapy. As a result, HIV can persist in tissue reservoirs for years.

Labelling 145
article thumbnail

Dupixent face rash and redness: Causes and treatment

The Checkup by Singlecare

How Dupixent works in the body It’s still unclear what causes atopic dermatitis , the most common form of adult and pediatric eczema, but it’s commonly regarded as an immune system and skin barrier condition. Those intruders trigger the immune system, which releases certain proteins that cause skin inflammation.

article thumbnail

Developing a new treatment paradigm for chronic kidney disease

European Pharmaceutical Review

This leads to the formation of immune complexes that deposit in the glomerulus and result in haematuria, proteinuria, and decline in kidney function. The mechanism of action of atacicept targets the origin of IgAN pathology, acting upstream of the disease-causing events. IgAN is the most common primary glomerulonephritis worldwide.

article thumbnail

Developing a new treatment paradigm for IgAN

European Pharmaceutical Review

This leads to the formation of immune complexes that deposit in the glomerulus and result in haematuria, proteinuria, and decline in kidney function. The mechanism of action of atacicept targets the origin of IgAN pathology, acting upstream of the disease-causing events. IgAN is the most common primary glomerulonephritis worldwide.

article thumbnail

Low Dose Naltrexone and Hashimoto’s

The Thyroid Pharmacist

However, low doses of this medication (hence, low dose naltrexone or LDN), have been found to modulate the immune system and have shown promise in improving cases of autoimmune disease. These include Crohn’s, MS, and Hashimoto’s, as well as other immune system-related conditions such as cancer and HIV/AIDS. Doses of 1.5-4.5